anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antikörper

Bezeichnung:
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Antikörper (RELB)
Auf www.antikoerper-online.de finden Sie aktuell 163 V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antikörper von 22 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Kits (23) und V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Proteine (10) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 212 V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Produkte verfügbar.
Synonyme:
GC-rich, I-REL, IREL, REL-B, relb-A, shep, XRelB

Meistgesuchte Reaktivitäten zu anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Mouse (Murine) Antikörper:

anti-Human Antikörper:

anti-Rat (Rattus) Antikörper:

Alle verfügbaren anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Antikörper

  1. Human Polyclonal RELB Primary Antibody für IHC (p), WB - ABIN197016 : Marienfeld, Berberich-Siebelt, Berberich, Denk, Serfling, Neumann: Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control. in Oncogene 2002 (PubMed)
    Zeige alle 3 Referenzen für 197016

  2. Human Polyclonal RELB Primary Antibody für WB - ABIN197500 : Pyz, Naidenko, Miyake, Yamamura, Berberich, Cardell, Kronenberg, Herrmann: The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. in Journal of immunology (Baltimore, Md. : 1950) 2006 (PubMed)
    Zeige alle 2 Referenzen für 197500

  3. Cow (Bovine) Polyclonal RELB Primary Antibody für WB - ABIN2780295 : Phan, Cho, Sainz-Lyon, Shin, Greenhalgh: CD14-dependent modulation of NF-kappaB alternative splicing in the lung after burn injury. in Gene 2006 (PubMed)

Weitere Antikörper gegen V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Interaktionspartner

Mouse (Murine) V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Interaktionspartner

  1. CCR7 (zeige CCR7 Antikörper) overexpression and RelB knockdown (KD) in imDCs improve skin-graft survival in a murine skin-transplantation model. Transfection with Ad-CCR7 (zeige CCR7 Antikörper) and RelB KD in imDCs may be an effective approach inducing immune tolerance, thus being potentially valuable for inhibiting allograft rejection.

  2. RelB is processed by CO2 in a manner dependent on a key C-terminal domain located in its transactivation domain. Loss of the RelB transactivation domain alters NF-kappaB (zeige NFKB1 Antikörper)-dependent transcriptional activity, and loss of p100 (zeige PATL2 Antikörper) alters sensitivity of RelB to CO2

  3. this study shows that RelB-silencing in dendritic cells generates dendritic cells of tolerogenic properties with immunomodulatory function and appears as potential option of cell-targeted therapy

  4. AhR and NF-kappaB/Rel protein binding profile within the 3'IghRR mediates the inhibitory effects of TCDD on Ig expression and therefore antibody levels.

  5. Relb is necessary for the effective production of downstream RANK(+) medullary thymic epithelial cell progenitors.

  6. we identify in this study a critical role for the combined activity of the RELB and NF-kappaB2 subunits in B cell homeostasis that cannot be compensated for by the canonical NF-kappaB (zeige NFKB1 Antikörper) pathway under physiological conditions.

  7. results indicate that BAFF (zeige TNFSF13B Antikörper) signals coordinate both RelB and cRel activities to ensure survival during peripheral B-cell maturation (zeige TNFRSF17 Antikörper)

  8. phosphorylation of DBC1 (zeige DBC1 Antikörper) at its C terminus by IKKalpha (zeige CHUK Antikörper) facilitates its interaction with RelB and IKKalpha (zeige CHUK Antikörper), indicating that DBC1 (zeige DBC1 Antikörper)-mediated suppression of alternative NF-kappaB (zeige NFKB1 Antikörper) is regulated by IKKalpha (zeige CHUK Antikörper).

  9. Data show that IL-1 (zeige IL1A Antikörper)-induced transcriptin factor RelB/NF-kappa B p50 (zeige NFKB1 Antikörper) Subunit complex formation was further promoted by oncostatin M (zeige OSM Antikörper) and that these complexes directly bound to the secreted protein cartilage glycoprotein 39 (YKL-40 (zeige CHI3L1 Antikörper)) promoter.

  10. RelB serine 472 phosphorylation status controls MMP3 (zeige MMP3 Antikörper) expression and promigration activity downstream of TNF (zeige TNF Antikörper) receptors.

Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Interaktionspartner

  1. Low RELB expression is associated with Prostate Cancer.

  2. NF-kappaB (zeige NFKB1 Antikörper) RelB protein, but not RelA (zeige NFkBP65 Antikörper), displayed high expression in Endometrial cancer samples and cell lines.

  3. to elucidate the induced activation of lytic pathway by ionizing radiation, irradiated SNU-719 cells were checked for the RelA (zeige NFkBP65 Antikörper) and RelB expression by real-time PCR. RelB level showed a dose-dependent enhancement on 2nd and 4th day, whereas only a slight upregulation in RelA (zeige NFkBP65 Antikörper) is noticed

  4. RelB is processed by CO2 in a manner dependent on a key C-terminal domain located in its transactivation domain. Loss of the RelB transactivation domain alters NF-kappaB (zeige NFKB1 Antikörper)-dependent transcriptional activity, and loss of p100 (zeige CUX1 Antikörper) alters sensitivity of RelB to CO2

  5. EZH2 (zeige EZH2 Antikörper), through a methyltransferase-independent mechanism, promotes the transcriptional activation of the non-canonical NF-kappaB (zeige NFKB1 Antikörper) subunit RelB

  6. The altered expression of anti-apoptotic gene Bcl-2 (zeige BCL2 Antikörper) played critical roles in regulating both spontaneous and radiation-induced apoptosis in the presence of RelB knockdown. For the first time, we showed that RelB knockdown significantly attenuated the migration and invasion of DU145 prostate cancer cells, due to the reduction of integrin b-1

  7. Knockdown of ADGRG2 breast cancer cell lines resulted in a strong reduction in cell adhesion and subsequent cell migration which was associated with a selective reduction in RelB.

  8. the role of RelB on lymphocyte development in humans was shown.

  9. In conclusion, DECs show a unique hypo-responsive phenotype to the pro-inflammatory stimulus LPS (zeige IRF6 Antikörper) in order to control the inflammatory response at feto-maternal interface.

  10. Lung-specific (CC-16) and novel (RelB) biomarkers are associated with systemic cardiovascular changes over time.

Cow (Bovine) V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Interaktionspartner

  1. Bovine foamy virus transactivator BTas interacts with cellular RelB to enhance viral transcription.

Xenopus laevis V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Interaktionspartner

  1. XRelB can partially substitute for several, but not all, functions of the Dorsal protein in Drosophila embryos.

V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antigen-Profil

Beschreibung des Gens

NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF- kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF- kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. Stimulates promoter activity in the presence of p49- and p50-NF-kappa-B. Neither associates with DNA nor with p65-NF-kappa-B (By similarity).

Alternative names and synonyms associated with V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB)

  • avian reticuloendotheliosis viral (v-rel) oncogene related B (Relb) Antikörper
  • v-rel avian reticuloendotheliosis viral oncogene homolog B (RELB) Antikörper
  • v-rel avian reticuloendotheliosis viral oncogene homolog B (Relb) Antikörper
  • v-rel avian reticuloendotheliosis viral oncogene homolog B (relb) Antikörper
  • v-rel reticuloendotheliosis viral oncogene homolog B (RELB) Antikörper
  • GC-rich Antikörper
  • I-REL Antikörper
  • IREL Antikörper
  • REL-B Antikörper
  • relb-A Antikörper
  • shep Antikörper
  • XRelB Antikörper

Bezeichner auf Proteinebene für RELB

transcription factor RelB , v-rel avian reticuloendotheliosis viral oncogene homolog B (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) , v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 , avian reticuloendotheliosis viral (v-rel) oncogene related B , v-rel reticuloendotheliosis viral oncogene homolog B , transcription factor RelB homolog

GENE ID SPEZIES
19698 Mus musculus
5971 Homo sapiens
100360982 Rattus norvegicus
522670 Bos taurus
378663 Xenopus laevis
484454 Canis lupus familiaris
100622609 Sus scrofa
395656 Gallus gallus
Ausgewählte Anbieter für anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antikörper
Haben Sie etwas anderes gesucht?